The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your
interaction with the ARDC and use of our national research infrastructure and services. The survey will take
approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure
services including Reasearch Link Australia.
We will use the information you provide to improve the national research infrastructure and services we
deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research
Infrastructure Strategy (NCRIS) program.
Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.
Complete the 5 min survey now by clicking on the link below.
Infertility remains a devastating disease for many couples, despite the success of IVF, as treatment is often unsuccessful, or remains out-of-reach for both health and/or financial reasons. My fellowship aims to improve our understanding of some of the causes of infertility in women. This will translate to a new infertility treatment that is safer for their health and provides for improved long-term health outcomes for their children.
The Legacy Of The Egg: How Maternal Factors Set Offspring Health And Lifecourse Potential
Funder
National Health and Medical Research Council
Funding Amount
$697,605.00
Summary
Before an oocyte is fertilised, it contains all the material needed to form an embryo, and a legacy of information about its environment. My research aims to discover how oocyte signals, accumulated before conception, determine the health of the future individual; and then harness this knowledge to improve female reproductive health and generate new approaches to treat infertility and to optimise healthy embryo development in all pregnancies.
Mechanistic And Translational Studies In Female Reproductive Health
Funder
National Health and Medical Research Council
Funding Amount
$631,370.00
Summary
The womb is essential for a health pregnancy. This research aims to determine how the womb interacts with embryos to ensure a healthy pregnancy forms. Cells in the womb can also grow abnormally and result in endometrial cancer. New treatments for endometrial cancer will also be tested in this research.
Whether we are born as a male or a female affects our sense of social place, behaviour, gender identity, reproductive options, and disease susceptibility. I am a molecular geneticist investigating the biology of gender. I study the mechanisms underpinning sexual development, with an emphasis on identifying the genetic causes of ‘intersex’ and transsex disorders. I am also studying how SRY, a male gene, controls voluntary movement, and its possible link to Parkinson’s disease.
I am a developmental biologist studying how transcription factors regulate developmental processes. I have a particular interest in the MYST family of co-activators, their role in regulating self-renewal and lineage determination in stem cells, their role in oncogenesis and targeting these proteins to develop new cancer therapeutics.
Implantation of an embryo into the uterus & development of a functional placenta are critical to initiate & continue a pregnancy. Implantation failure causes infertility and is a major bottle-neck in IVF. Placental insufficiency leads to pregnancy loss, under-developed fetuses & a life-threatening pregnancy-specific disease preeclampsia. This application will investigate how a woman’s uterus works for implantation and placental development, how to increase IVF success and diagnose & potentially ....Implantation of an embryo into the uterus & development of a functional placenta are critical to initiate & continue a pregnancy. Implantation failure causes infertility and is a major bottle-neck in IVF. Placental insufficiency leads to pregnancy loss, under-developed fetuses & a life-threatening pregnancy-specific disease preeclampsia. This application will investigate how a woman’s uterus works for implantation and placental development, how to increase IVF success and diagnose & potentially treat preeclampsia.Read moreRead less
Dr Gilchrist is a reproductive biologist studying factors that regulate the intrinsic quality of unfertilised eggs. He has developed a new form of hormone-free infertility treatment which he will test in a clinical trial over the next 5 years.
Improving The Prevention, Treatment And Management Of Cardiovascular & Chronic Disease In The Community
Funder
National Health and Medical Research Council
Funding Amount
$774,540.00
Summary
The identification, prevention and management of cardiovascular and chronic disease risk factors and understanding impact on clinical outcomes is fundamental to improving health and well-being. The program of work encapsulated in this application utilises modern epidemiological research methods involving large scale clinical trials, registries and epidemiological modelling to advance our understanding and provide new directions for cardiovascular disease prevention and management.
Ovarian and endometrial cancer affect >3,200 women each year in Australia and 3 or 4 women die from these cancers every day. The overall aim of my program of research is to reduce the burden of these cancers in future generations of Australian women by increasing our understanding of (i) what causes them, (ii) how we can optimise patient management to enhance patient outcomes and (ii) how lifestyle changes might improve quality and life and survival, for women who are diagnosed with them.
Striking The Balance: Combining Best Patient Outcomes And Cost-effective Interventions To Manage Cardiovascular Disease
Funder
National Health and Medical Research Council
Funding Amount
$782,370.00
Summary
This research will combine effective patient outcomes with strategic spending of health dollars. Through detailed analyses of current and recent clinical trials on cardiovascular disease, this project will identify treatments that provide the most benefit to patients’ quality of life and, crucially, will also be the most cost-effective to fund. This will pave the way for similar processes to be used in other areas of health to develop cost-effective healthcare programs for vulnerable groups.